Disclaimer: Novartis AG is an investor in H1 Insights, Inc.
In a complex pharmaceutical environment, Medical Affairs teams are constantly striving to demonstrate value and measure impact. In pursuing these metrics it is important to understand, define and quantify impact and differentiate it from “activity.”
By examining the historical perspective on value, identifying areas of opportunity with current available data, and pushing teams to put our patients at the center of our efforts, we can begin implementing novel impact methodologies.
The views and opinions expressed in this presentation are those of the author and do not necessarily reflect the official policy or position of Novartis or any of its officers.